AI Summary

The emergence of prediction markets on Kalshi and Polymarket, which enable individuals to wager on drug approvals, has raised concerns about the potential impact on research. These platforms allow users to place bets on the outcome of clinical trials and regulatory decisions, which could create financial incentives for researchers to manipulate trial results or influence approval processes. The involvement of financial interests in the research process may compromise the integrity of the scientific method. Kalshi's plan to expand its platform to include bets on clinical trial results further underscores the need for scrutiny of these prediction markets and their potential effects on the pharmaceutical industry.

AI summaries can be wrong sometimes—always verify important details using the source article.